PACB
Pacific Biosciences of California Inc
Price:  
1.13 
USD
Volume:  
5,900,072.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PACB WACC - Weighted Average Cost of Capital

The WACC of Pacific Biosciences of California Inc (PACB) is 8.3%.

The Cost of Equity of Pacific Biosciences of California Inc (PACB) is 10.90%.
The Cost of Debt of Pacific Biosciences of California Inc (PACB) is 7.00%.

Range Selected
Cost of equity 8.70% - 13.10% 10.90%
Tax rate 0.10% - 1.50% 0.80%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.6% - 9.0% 8.3%
WACC

PACB WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.06 1.47
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.70% 13.10%
Tax rate 0.10% 1.50%
Debt/Equity ratio 1.91 1.91
Cost of debt 7.00% 7.00%
After-tax WACC 7.6% 9.0%
Selected WACC 8.3%

PACB's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for PACB:

cost_of_equity (10.90%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (1.06) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.